Seeking Alpha

Arena Pharmaceuticals (ARNA -0.1%) enters into a co-development and license agreement with...

Arena Pharmaceuticals (ARNA -0.1%) enters into a co-development and license agreement with Ildong Pharmaceutical for Temanogrel, ARNA's treatment for for myocardial infarction, acute coronary syndrome, stroke, peripheral artery disease, and other cardiovascular diseases, subject to the drug's further development and regulatory approval. The agreement grants Ildong exclusive rights to commercialize and market the drug.
Comments (7)
  • excellent news but the source is no clear please let us know the source of this news. Thanks for the alert
    28 Nov 2012, 01:57 PM Reply Like
  • It came from an Arena press release this morning...
    http://bit.ly/Su5Yoo
    28 Nov 2012, 04:45 PM Reply Like
  • Ildong Pharmaceutical & ARNA announced...Jack Leaf made statement very early this morning.
    28 Nov 2012, 02:39 PM Reply Like
  • You might think that this news would bump ARNA a little higher. But no such good fortune.

     

    Long ARNA and loving any positive news for the company.
    28 Nov 2012, 03:05 PM Reply Like
  • Thanks for sharing the source of news.

     

    Best regards..................
    28 Nov 2012, 06:10 PM Reply Like
  • we have news for Arena why the stock is beating down Why???
    29 Nov 2012, 03:26 AM Reply Like
  • is IIdong the same as Phizer?
    That's why the stock market said "Ho Hum, Yawn"
    29 Nov 2012, 05:56 AM Reply Like
DJIA (DIA) S&P 500 (SPY)